Dr. Tawanda Nyambuya

Tawanda Nyambuya is an academic researcher whose work centers on metabolic diseases, cardiovascular risk, and immunometabolic regulation. His scholarship explores the interplay between inflammation, oxidative stress, and cardiometabolic disorders, with particular attention to type 2 diabetes, obesity, and hypertension. Through integrative and translational approaches, his research bridges molecular mechanisms with clinical implications.

A significant focus of his publications is brown and beige adipose tissue biology, thermogenesis, and metabolic dysfunction, highlighting therapeutic targets such as metformin, nutraceuticals like epigallocatechin gallate, and coenzyme Q10. His reviews synthesize mechanistic and clinical evidence to clarify how mitochondrial function, lipid metabolism, and inflammatory pathways contribute to cardiometabolic complications.

Nyambuya has also contributed to systematic reviews and meta-analyses in hematology and immunology, including work on leukemia, allergic inflammation, and prognostic biomarkers. His research demonstrates strength in evidence synthesis, risk stratification, and identification of inflammatory markers as therapeutic targets, supporting improved management strategies for chronic and immune-related diseases.